Literature DB >> 26254684

Neoadjuvant chemoradiation in oesophageal cancer.

Christophe Mariette1, William B Robb2, Guillaume Piessen3, Antoine Adenis4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26254684     DOI： 10.1016/S1470-2045(15)00127-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  The therapeutic response of CDDO-Me in the esophageal squamous cell carcinoma (ESCC) cells is mediated by CaMKIIα.

Authors:  Yan-Yang Wang; Shun Zhou; Ren Zhao; Ping Hai; Hong Zhe
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

2.  SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy.

Authors:  Yifei Yun; Yutong Zhang; Qiqi Xu; Yao Ou; Xifa Zhou; Zhonghua Lu
Journal:  Cell Death Discov       Date:  2022-05-25

3.  Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.

Authors:  Xingxing Wang; Hao Wang; Haixing Wang; Jie Huang; Xin Wang; Zhengzeng Jiang; Lijie Tan; Dongxian Jiang; Yingyong Hou
Journal:  BMC Cancer       Date:  2021-02-03       Impact factor: 4.430

4.  FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma.

Authors:  Zuoquan Zhu; Jiahang Song; Junjie Gu; Bing Xu; Xinchen Sun; Shu Zhang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

5.  Treatment of esophageal cancer with radiation therapy -a pan-Chinese survey of radiation oncologists.

Authors:  Yun Zhang; Jing Liu; Wencheng Zhang; Weiye Deng; Jinbo Yue
Journal:  Oncotarget       Date:  2017-05-23

6.  Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification.

Authors:  Dongxian Jiang; Hao Wang; Qi Song; Haixing Wang; Qun Wang; Lijie Tan; Yingyong Hou
Journal:  J Cancer       Date:  2020-01-20       Impact factor: 4.207

7.  Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.

Authors:  Jingyang Wu; Jiansheng Yang; Xianbin Lin; Liang'an Lin; Wentan Jiang; Chengke Xie
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.